학술논문
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
Document Type
Article
Author
Balakrishnan, K; Burton, T; Cannon, J; Collier, D; Coughlan, C; D'Souza, R; Enobakhare, E; Findlay, E; Gardiner-Hill, C; Gupta, P; Helmy, J; Helmy, C; Hobbs, L; Hobbs, R; Hood, S; Iles, R; Kean, S; Kwok, S; Lacy, P; MacIntyre, I; Mackay, J; Markandu, N; Martin, U; McCallum, L; McCann, G; McGinnis, A; Melville, V; Muir, S; Myint, KS; Nazir, S; Palmer, J; Papworth, R; Rutkowski, K; Saxena, M; Schumann, A; Soran, H; Stanley, A; Thom, S; Webb, A; White, C; Wilson, R; Zak, A; Williams, Bryan; MacDonald, Thomas M; Morant, Steve V; Webb, David J; Sever, Peter; McInnes, Gordon T; Ford, Ian; Cruickshank, J Kennedy; Caulfield, Mark J; Padmanabhan, Sandosh; Mackenzie, Isla S; Salsbury, Jackie; Brown, Morris J
Source
In The Lancet Diabetes & Endocrinology June 2018 6(6):464-475
Subject
Language
ISSN
2213-8587